|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 250.09 USD | +0.85% |
|
+2.58% | +9.45% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 08-11 | BNP Paribas Adjusts Price Target on AbbVie to $247 From $218, Maintains Neutral Rating | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 253.3 | 263.3 | 261.07 |
| Spread/Res. | -1.27% | -5.02% | -4.21% |
| Spread/Supp. | +2.58% | +9.82% | +9.82% |
| Support | 243.8 | 227.73 | 227.73 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ABBV Stock
- Charts AbbVie Inc.
Select your edition
All financial news and data tailored to specific country editions
